Has Krystal Coleman received payments from drug or device companies?

Yes. Drug and device makers reported $2,004 in general payments to Krystal Coleman across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Krystal Coleman did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Krystal Coleman come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Krystal Coleman

Nurse Practitioner · Stony Point, NCNPI 1477053718

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations.

$2,004in general payments, 2019–2025

Across 97 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$346
AbbVie$281
GSK$242
Johnson & Johnson$173
Pfizer$144
Sunovion Pharmaceuticals Inc.$105
plus $713 from 15 others

What the payments were for

Food & beverage$2,004100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	12	$346
AbbVie	11	$281
GSK	9	$242
Johnson & Johnson	6	$173
Pfizer	10	$144
Sunovion Pharmaceuticals Inc.	6	$105
Kowa Pharmaceuticals America, Inc.	6	$102
AstraZeneca	6	$89
Lilly USA, LLC	5	$86
Boehringer Ingelheim	4	$73
Sanofi-aventis U.S. LLC	4	$66
Philips North America LLC	3	$55
Takeda Pharmaceuticals U.S.A., Inc.	3	$45
Nestle Healthcare Nutrition Inc.	3	$42
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$35
Novartis	2	$27
Xeris Pharmaceuticals, Inc.	1	$23
Arbor Pharmaceuticals, Inc.	1	$22
Abbott	1	$18
Amarin Pharma, Inc.	1	$17
E.r. Squibb & Sons, L.L.C.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,004 in reported general payments places this provider in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina →

Other nurse practitioner in Stony Point

Sandrivette JohnsonRaleigh$573K
Ayeshia WrightMocksville$145K
Jeanann VawterGastonia$97K
Terra KampJacksonville$72K
Mary DilorenzoCharlotte$71K
Olivia OgburnWinston Salem$70K
Bridget ArchambaultDurham$57K
Deborah MayerChapel Hill$55K
Amber SeilerGreensboro$55K
Stephanie PascaleRaleigh$54K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →